Avadel Pharmaceuticals PLC (AVDL) — Cash Flow Reinvestment Rate
Avadel Pharmaceuticals PLC (AVDL) has a Cash Flow Reinvestment Rate of 0.36x as of September 2025, reinvesting $8.44 Million (capex $10.76K plus investments $-8.43 Million) from operating cash flow of $23.26 Million. See Avadel Pharmaceuticals PLC (AVDL) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Avadel Pharmaceuticals PLC Cash Flow Reinvestment Rate (2002–2017)
Historical reinvestment intensity for Avadel Pharmaceuticals PLC across 6 annual periods. For the full cash flow conversion analysis, see Avadel Pharmaceuticals PLC operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Avadel Pharmaceuticals PLC (2002–2017)
Year-by-year capital reinvestment analysis for Avadel Pharmaceuticals PLC. See Avadel Pharmaceuticals PLC financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2017 | 5.50x | $91.71 Million | $16.66 Million | $53.70 Million | ▲ +179.2% |
| 2016 | 1.97x | $37.26 Million | $18.90 Million | $1.20 Million | ▲ +423.7% |
| 2015 | 0.38x | $31.73 Million | $84.29 Million | $1.63 Million | ▲ +74.3% |
| 2009 | 0.22x | $1.77 Million | $8.20 Million | $1.77 Million | ▼ -7.0% |
| 2003 | 0.23x | $2.84 Million | $12.23 Million | $2.84 Million | ▲ +42.0% |
| 2002 | 0.16x | $1.44 Million | $8.77 Million | $1.44 Million | — |